Creative Medical Technology Holdings (CELZ) Assets (2010 - 2026)
Creative Medical Technology Holdings' (CELZ) quarterly Assets came in at $9.4 million in Q2 2026, up 31.98% year-over-year from $7.1 million in Q2 2025, and up 45.6% quarter-over-quarter from $6.4 million in Q1 2026.
Analysis
Creative Medical Technology Holdings (CELZ) Assets (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Assets for 17 consecutive years, with $9.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets rose 31.98% year-over-year to $9.4 million in Q2 2026; TTM through Jun 2026 was $9.4 million, a 31.98% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 17.1% from the prior year.
- Assets was $9.4 million for Q2 2026 at Creative Medical Technology Holdings, up from $6.4 million in the prior quarter.
- Over five years, Assets peaked at $23.4 million in Q2 2022 and troughed at $5.9 million in Q3 2025.
- A 5-year average of $11.3 million and a median of $9.5 million in 2024 frame the typical range for Assets.
- Across the five-year window, Assets surged 3100.04% in 2022 and slumped 44.96% in 2024, its largest moves.
- Over 5 years, Assets stood at $19.2 million in 2022, then plunged by 44.15% to $10.7 million in 2023, then plunged by 37.76% to $6.7 million in 2024, then advanced by 17.1% to $7.8 million in 2025, then climbed by 20.08% to $9.4 million in 2026.
- The last three Assets figures came in at $9.4 million (Q2 2026), $6.4 million (Q1 2026), and $7.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 1.50 Bn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 2.65 Bn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 915.53 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 1.75 Bn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 985.10 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 1.39 Bn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 170.30 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 3.19 Bn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 502.87 Mn |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - | 9.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.38 Mn |
| Mar 31, 2026 | 6.44 Mn |
| Dec 31, 2025 | 7.81 Mn |
| Sep 30, 2025 | 5.85 Mn |
| Jun 30, 2025 | 7.11 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 6.67 Mn |
| Sep 30, 2024 | 6.89 Mn |
| Jun 30, 2024 | 7.99 Mn |
| Mar 31, 2024 | 9.62 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Sep 30, 2023 | 12.51 Mn |
| Jun 30, 2023 | 14.13 Mn |
| Mar 31, 2023 | 15.23 Mn |
| Dec 31, 2022 | 19.19 Mn |
| Sep 30, 2022 | 22.47 Mn |
| Jun 30, 2022 | 23.43 Mn |
| Mar 31, 2022 | 9.73 Mn |
| Dec 31, 2021 | 11.27 Mn |
| Sep 30, 2021 | 3.13 Mn |